This trial is evaluating whether Mango consumption will improve 6 primary outcomes and 19 secondary outcomes in patients with Metabolic Syndrome. Measurement will happen over the course of 8 weeks.
This trial requires 35 total participants across 2 different treatment groups
This trial involves 2 different treatments. Mango Consumption is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
Metabolic syndrome cannot be cured. Patients must be encouraged to get checked periodically with appropriate treatment, and patients with MetS need to keep healthy weight and reduce the level of LDL and hypertension to lower the mortality rate.
Abetting on one hand the excess weight gain in an adult and on the other hand the insulin resistance may result in the onset of MS in individuals from different social groups, although not every person that develops MS has metabolic syndrome.
MetS was uncommon in the non-Hispanic black population. Higher prevalences in subgroups were observed compared to the whole population. Findings of the present study have highlighted important aspects regarding socioeconomic, geographic, racial and ethnic differences in MetS prevalence.
Metabolic syndrome can lead to several complications. These include cardiovascular diseases, type 2 diabetes, sleep apnea, and infertility. Thus, treatment for metabolic syndrome is tailored to the specific patient to achieve the highest therapeutic benefit.
MetS is a syndrome that is defined by four components: central obesity, high blood pressure, high fasting and postprandial TG, and low HDL. MetS is found in many different age groups and racial groups. It is a highly prevalent disorder with the highest prevalence observed among the elderly, although its occurrence is increasing in other age groups.
Data from a recent study suggest that a daily consumption of two or more servings of fruit provides no additional benefits in the control of LDL-C levels, glycemic control, or the incidence of CV disease (eg, MI, stroke or HF) in people without and with MetS. The safety of mango consumption may be further explored in clinical trials.
[Metabolic syndrome]] occurs at about the age of 44-48. This information is helpful for [primary care providers] to understand and counsel patients with metabolic syndrome.
There are several effective [treatments to decrease BMI, blood pressure, and cholesterol levels] (https://www.ncbi.nlm.nih.gov/books/bv.fcgi#health_competencies#cholesterol_and_metabolic_diseases_and_cohort_comparisons), but some treatment options are still not available in the clinic (https://www.nypcc.
The consumption of ripe mangos at appropriate levels seems to be safe. Nevertheless, caution should be exercised when buying fresh mangos to consume (all fruits in their natural form should not be consumed) as they may contain tiny particles of aluminum, which can cause a mild metal poisoning in some people. [Power] Please seek advice from a personal health professional about appropriate use of mango and other fruits before beginning consumption.
There are four risk factors of metabolic syndrome including central adiposity, high blood pressure, high blood lipids, and low blood calcium. The central adiposity is the main cause of metabolic syndrome because it is the cause of central fat accumulation in the body. Other causes for metabolic syndrome are [high blood lipids (hyperlipidemia) and low blood calcium (hypocalcemia)]? This article will show how central adiposity causes metabolic syndrome.
This review describes recent research about the therapeutic benefits of mango consumption, while also highlighting potential adverse effects. Although more in vivo studies are required to elucidate the mechanisms of these potential adverse effects, it may be a matter of time before mango as food is routinely evaluated as a medicine.